ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.01 and traded as high as $0.01. ProtoKinetix shares last traded at $0.01, with a volume of 107,500 shares.
ProtoKinetix Stock Up 26.3 %
The company’s fifty day moving average is $0.01 and its 200-day moving average is $0.02.
ProtoKinetix Company Profile
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.
Featured Stories
- Five stocks we like better than ProtoKinetix
- Basic Materials Stocks Investing
- RXO Shares Surge Following New Acquisition Deal
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Short Selling: How to Short a Stock
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
